| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |